Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims.
The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR.
National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.
The Los Angeles-based imaging center operator recently reached a deal to acquire AI firm Gleamer for $270 million, on top of spending $74 million to add over a dozen imaging centers.
Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J.
Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.
Typically, these cancers are treated via surgical resection, but ablative techniques have gained recognition in recent years due to their less invasive nature.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
